Zapping anxiety: head device shows promise for young adults with GAD

NCT ID NCT06124014

Completed Symptom relief Sponsor: Electromedical Products International, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called cranial electrotherapy stimulation (CES) for treating generalized anxiety disorder in 130 young adults aged 18-21. Participants used the device at home for 60 minutes daily over six weeks. The goal was to see if CES reduces anxiety symptoms compared to a sham (fake) device. Results may show whether this drug-free approach can help ease anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cranial electrotherapy stimulation (CES) device
What this could lead to: If it works, this could offer a drug-free option to ease anxiety symptoms in young adults with generalized anxiety disorder.
What could go wrong: This is a completed trial, but results are not yet widely confirmed. The effect may be small or similar to a placebo, and it only tested people aged 18-21.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

generalized anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENERALIZED ANXIETY DISORDER

Contacts and locations

Locations

Carolina Center for Neurostimulation

Chapel Hill, North Carolina, 27516, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.